Related Experiment Video
Updated: Sep 26, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
The block of ryanodine receptors selectively inhibits fetal myoblast differentiation
Alessandro Pisaniello1, Carlo Serra, Daniela Rossi
1Department of Histology and Medical Embryology, University of Rome 'La Sapienza', 00161 Rome, Italy.
Abstract:
Differentiation and morphogenesis of skeletal muscle are complex and asynchronous events that involve various myogenic cell populations and extracellular signals. Embryonic and fetal skeletal myoblasts are responsible for the formation of primary and secondary fibers, respectively, although the mechanism that diversifies their fate is not fully understood. Calcium transients appear to be a signaling mechanism that is widely utilized in differentiation and embryogenesis. In mature skeletal muscle, calcium transients are generated mainly by ryanodine receptors (type 1 and type 3), which are involved in excitation-contraction coupling. However, it is not clear whether the activity of these receptors is important for contractile activity alone or whether it may also play a role in regulating the differentiation/developmental processes. To clarify this point, we first examined the expression of the receptors during development. The results show that the expression of both receptors appears as early as E13 during limb muscle development and parallels the expression of skeletal myosin. The expression and the activity of both receptors is maintained in vitro by all myogenic cell populations isolated from different stages of development, including somitic, embryonic and fetal myoblasts and satellite cells. Blocking ryanodine receptor activity by using ryanodine inhibits in vitro differentiation of fetal myoblasts (judged by the expression of sarcomeric myosin and formation of multinucleated myotubes) but not of somitic or embryonic and satellite muscle cells. This block is caused by the transcriptional inhibition of markers characteristic of terminal differentiation, rather than commitment, as the expression of muscle regulatory factors is not impaired by ryanodine treatment. Taken together, the data reported in this paper demonstrate that, although calcium transients represent a general mechanism for the control of differentiation and development, multiple calcium-dependent pathways may be relevant in different myogenic populations during development. Moreover, since fetal myoblasts are responsible for the formation of secondary fibers during development, and therefore for the building of the bulk of muscular mass, these results suggest that calcium release from ryanodine receptors plays a role in the histogenesis of mammalian skeletal muscle.
Insights
Ryanodine receptors control skeletal muscle development. Blocking these receptors inhibits fetal myoblast differentiation, suggesting their crucial role in muscle histogenesis and mass development.
Area of Science:
- Muscle biology
- Developmental biology
- Cell signaling
Background:
- Skeletal muscle development involves complex differentiation and morphogenesis of various myogenic cells.
- Calcium transients are critical signaling mechanisms in embryogenesis and differentiation.
- Ryanodine receptors (RyRs) generate calcium transients in mature muscle, but their developmental role is unclear.
Purpose of the Study:
- Investigate the role of ryanodine receptors (RyRs) in skeletal muscle differentiation and development.
- Determine if RyR activity is essential for contractile function or developmental processes.
- Clarify the specific contribution of RyRs to different myogenic cell populations.
Main Methods:
- Examined RyR expression during limb muscle development (E13 onwards).
- Assessed RyR expression and activity in various isolated myogenic cell populations in vitro.
- Utilized ryanodine to block RyR activity and observed effects on myoblast differentiation.
Main Results:
- RyR expression (types 1 and 3) begins at E13, paralleling skeletal myosin expression.
- RyRs are expressed and active in somitic, embryonic, fetal myoblasts, and satellite cells in vitro.
- Ryanodine treatment inhibited fetal myoblast differentiation (sarcomeric myosin, myotube formation) but not other cell types.
- Inhibition occurred at the transcriptional level of terminal differentiation markers, not commitment factors.
Conclusions:
- Calcium transients are general regulators of muscle differentiation, but pathways vary among myogenic populations.
- Ryanodine receptor activity is crucial for fetal myoblast differentiation and secondary fiber formation.
- RyR-mediated calcium release plays a significant role in mammalian skeletal muscle histogenesis.
Related Concept Videos
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Depolarizing Blockers: Pharmocokinetics
Antihypertensive Drugs: Action of Calcium Channel Blockers
